Literature DB >> 23256791

The future of CpG immunotherapy in cancer.

Behnam Badie, Jacob M Berlin.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23256791     DOI： 10.2217/imt.12.148

Source DB:  PubMed          Journal:  Immunotherapy        ISSN： 1750-743X            Impact factor:   4.196


× No keyword cloud information.
  8 in total

1.  Functionalized iron oxide nanoparticles for controlling the movement of immune cells.

Authors:  Ethan E White; Alex Pai; Yiming Weng; Anil K Suresh; Desiree Van Haute; Torkom Pailevanian; Darya Alizadeh; Ali Hajimiri; Behnam Badie; Jacob M Berlin
Journal:  Nanoscale       Date:  2015-05-07       Impact factor: 7.790

2.  High-Density Lipoprotein-Mimicking Nanodiscs for Chemo-immunotherapy against Glioblastoma Multiforme.

Authors:  Padma Kadiyala; Dan Li; Fernando M Nuñez; David Altshuler; Robert Doherty; Rui Kuai; Minzhi Yu; Neha Kamran; Marta Edwards; James J Moon; Pedro R Lowenstein; Maria G Castro; Anna Schwendeman
Journal:  ACS Nano       Date:  2019-02-11       Impact factor: 15.881

Review 3.  Harnessing Human Cross-Presenting CLEC9A(+)XCR1(+) Dendritic Cells for Immunotherapy.

Authors:  Kirsteen M Tullett; Mireille H Lahoud; Kristen J Radford
Journal:  Front Immunol       Date:  2014-05-22       Impact factor: 7.561

Review 4.  The role of key gut microbial metabolites in the development and treatment of cancer.

Authors:  Kayla Jaye; Chun Guang Li; Dennis Chang; Deep Jyoti Bhuyan
Journal:  Gut Microbes       Date:  2022 Jan-Dec

5.  The Biocomplex Assembled from Antigen Peptide and Toll-like Receptor Agonist Improved the Immunity against Pancreatic Adenocarcinoma In Vivo.

Authors:  Wenming Feng; Hongbin Yu; Tao Xue; Chunyong Wu; Fan Ren; Ge Cui
Journal:  J Oncol       Date:  2022-08-25       Impact factor: 4.501

Review 6.  Gold nanoparticle mediated cancer immunotherapy.

Authors:  Joao Paulo Mattos Almeida; Elizabeth Raquel Figueroa; Rebekah Anna Drezek
Journal:  Nanomedicine       Date:  2013-10-05       Impact factor: 5.307

7.  Metronomic Doses of Temozolomide Enhance the Efficacy of Carbon Nanotube CpG Immunotherapy in an Invasive Glioma Model.

Authors:  Mao Ouyang; Ethan E White; Hui Ren; Qin Guo; Ian Zhang; Hang Gao; Song Yanyan; Xuebo Chen; Yiming Weng; Anna Da Fonseca; Sunny Shah; Edwin R Manuel; Leying Zhang; Steven L Vonderfecht; Darya Alizadeh; Jacob M Berlin; Behnam Badie
Journal:  PLoS One       Date:  2016-02-01       Impact factor: 3.240

Review 8.  Nanomedicine-based immunotherapy for central nervous system disorders.

Authors:  Sumaira Hanif; Pir Muhammad; Rose Chesworth; Fawad Ur Rehman; Rong-Jun Qian; Meng Zheng; Bing-Yang Shi
Journal:  Acta Pharmacol Sin       Date:  2020-05-28       Impact factor: 6.150
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.